Pharmacists in New Albany, Indiana


92 Pharmacists found in New Albany
male pharmacist

Steven Daniel Doyen, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2910 Grant Line Rd, New Albany, IN 47150
812-944-1214    

male pharmacist

Steven R Ariens, PD


Pharmacist
2241 State St, New Albany, IN 47150
812-923-3434    

female pharmacist

Tahnee L Meyer, RPH


Pharmacist
1945 State St, New Albany, IN 47150
812-944-6500     812-944-6900



female pharmacist

Thi Phuong Khanh Duong


Pharmacist
2015 State St, New Albany, IN 47150
812-945-0535    

male pharmacist

Mr. Thomas Joseph Dykiel Ii, PHARM D.


Pharmacist
2015 State St, New Albany, IN 47150
812-945-0535     812-945-8249

male pharmacist

Dr. Travis Wayland Jones, PHARM.D.


Pharmacist
2022 E Spring St, New Albany, IN 47150
812-949-0641     812-949-1068

female pharmacist

Trisha Banet


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
200 New Albany Plz, New Albany, IN 47150
812-948-2701    

female pharmacist

Van N Spitler


Pharmacist
2755 Charlestown Rd, New Albany, IN 47150
812-246-1327    

female pharmacist

Whitney Nail, PHARMD


Pharmacist
2209 State St, New Albany, IN 47150
918-521-8085    

female pharmacist

Whitney Elnora Davis, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3400 Grant Line Rd, New Albany, IN 47150
812-948-1399     812-948-1095

male pharmacist

Dr. William Nathaniel Jones, PHARMD


Pharmacist
1950 State St, New Albany, IN 47150
812-948-2035    

female pharmacist

Yolanda Gales, PHARMD


Pharmacist
2015 State St, New Albany, IN 47150
812-945-0535    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.